Cargando…

Corrigendum: Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease

Detalles Bibliográficos
Autores principales:	Yamada, Zento, Nishio, Junko, Motomura, Kaori, Mizutani, Satoshi, Yamada, Soichi, Mikami, Tetuo, Nanki, Toshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155685/ https://www.ncbi.nlm.nih.gov/pubmed/37153581 http://dx.doi.org/10.3389/fimmu.2023.1201209

Ejemplares similares

Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease
por: Yamada, Zento, et al.
Publicado: (2022)

Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice
por: Mizutani, Satoshi, et al.
Publicado: (2021)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)

Management of patients with fibrosing interstitial lung diseases
por: Morrow, Lee E, et al.
Publicado: (2021)

Fibrosing interstitial lung diseases: knowns and unknowns
por: Cottin, Vincent, et al.
Publicado: (2019)

Biomarkers of Fibroproliferative Healing in Fibrosing Idiopathic Interstitial Pneumonias
por: Vasakova, Martina, et al.
Publicado: (2012)

The natural history of progressive fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2019)

The natural history of progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2020)

Management and support of patients with fibrosing interstitial lung diseases
por: Barbera, Tyonn, et al.
Publicado: (2021)

Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
por: Chen, Xianqiu, et al.
Publicado: (2021)

The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
por: Abu Qubo, Ahmad, et al.
Publicado: (2022)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Role of imaging in progressive-fibrosing interstitial lung diseases
por: Walsh, Simon L.F., et al.
Publicado: (2018)

Nintedanib in children and adolescents with fibrosing interstitial lung diseases
por: Deterding, Robin, et al.
Publicado: (2023)

Burden of illness in progressive fibrosing interstitial lung disease
por: Singer, David, et al.
Publicado: (2022)

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
por: Hoeper, Marius M., et al.
Publicado: (2015)

Diffuse pulmonary ossification associated with fibrosing interstitial lung disease
por: Alami, Badreeddine, et al.
Publicado: (2019)

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
por: Wollin, Lutz, et al.
Publicado: (2019)

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2021)

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
por: Kwon, Byoung Soo, et al.
Publicado: (2021)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
por: Copeland, Carla R., et al.
Publicado: (2021)

Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective
por: Albera, Carlo, et al.
Publicado: (2021)

Challenges in the Diagnosis and Management of Patients with Fibrosing Interstitial Lung Disease
por: Tolle, Leslie B.
Publicado: (2022)

Real-life prevalence of progressive fibrosing interstitial lung diseases
por: Gagliardi, Maureen, et al.
Publicado: (2021)

Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases
por: Lai, Yunxin, et al.
Publicado: (2021)

Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2022)

Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease
por: Watase, Mayuko, et al.
Publicado: (2023)

Cluster features in fibrosing interstitial lung disease and associations with prognosis
por: Wang, Yuanying, et al.
Publicado: (2023)

Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases
por: Kawazoe, Mai, et al.
Publicado: (2023)

Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study
por: Muraoka, Sei, et al.
Publicado: (2021)

Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias
por: Traila, Daniel, et al.
Publicado: (2017)

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
por: Cottin, Vincent
Publicado: (2019)

The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach
por: Wuyts, Wim A., et al.
Publicado: (2020)

Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020)

Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases
por: Torres, Pedro Paulo Teixeira e Silva, et al.
Publicado: (2021)

Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline
por: Nagy, Alexandra, et al.
Publicado: (2021)

Cardiorespiratory responses to muscle metaboreflex activation in fibrosing interstitial lung disease
por: Chen, Charlotte, et al.
Publicado: (2022)

Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
por: Guiot, Julien, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7mf9iluart9hgjv0ngu3gllfbu